A research team has developed a single-dose CRISPR-CasRx nanotherapy targeting the host enzyme cathepsin L (referred to as SCNC) that not only reduces SARS-CoV-2 viral load during acute infection but ...
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid. Part of a class of drugs known ...
Most of us now view COVID-19 as more of a nuisance than a danger, thanks to vaccines and past exposure to the virus—all of which have built up our immunity. But research suggests that multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results